BD Board Increases Dividend
FRANKLIN LAKES, N.J., Nov. 23, 2010 /PRNewswire-FirstCall/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 41 cents per common share, an increase of 4 cents per share, or 10.8%, from the previous quarter. The dividend will be payable on December 31, 2010 to holders of record on December 10, 2010. At the current rate, the annual dividend for fiscal year 2011 would be $1.64 cents per share.
"This marks the 38th consecutive year in which BD has increased our dividend, reflecting the Company's sustained strong performance and cash flow," said Edward J. Ludwig, BD Chairman and Chief Executive Officer. "We are pleased to be able to continue to create value for our shareholders while also making strategic investments for BD's future."
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
Contact: Colleen T. White, Corporate Communications – 201-847-5369 Zachary Nagle, Investor Relations – 201-847-5453
SOURCE BD (Becton, Dickinson and Company)
Released November 23, 2010